EUVIMEDEUVIMED entdecken
Leserbrief

Long-acting local anesthetics in nail surgery: Current evidence and future directions.Reply to “A Novel Utilization of Liposomal Bupivacaine in Nail Procedures”

Jose W Ricardo, Shari R Lipner

Journal of the American Academy of Dermatology · 2026-10

DOI: 10.1016/j.jaad.2026.08.140 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of the American Academy of Dermatology, 2026-10. Verfasst von Jose W Ricardo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

analgesiaanesthesiaavulsionbiopsybupivacainelidocaineliposomallocalnailsprocedurepunchropivacainesurgery

Autor:innen und Institutionen

  • Department of Dermatology, University of Nebraska Medical Center, Omaha, Nebraska.
  • Department of Dermatology, Weill Cornell Medicine, New York, New York. Electronic address: shl9032@med.cornell.edu.

Zitieren

APA

Ricardo, J. W., & Lipner, S. R. (2026). Long-acting local anesthetics in nail surgery: Current evidence and future directions.Reply to “A Novel Utilization of Liposomal Bupivacaine in Nail Procedures”. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.08.140

Vancouver

Ricardo JW, Lipner SR. Long-acting local anesthetics in nail surgery: Current evidence and future directions.Reply to “A Novel Utilization of Liposomal Bupivacaine in Nail Procedures”. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.08.140

BibTeX
@article{Ricardo2026,
  author = {Ricardo, Jose W and Lipner, Shari R},
  title = {Long-acting local anesthetics in nail surgery: Current evidence and future directions.Reply to “A Novel Utilization of Liposomal Bupivacaine in Nail Procedures”},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.08.140}
}
Kostenlos starten →